
CTKB Technical Analysis Summary (NASDAQ)
Analyze CTKB on the NASDAQ with RSI, MACD, ADX, Bollinger Bands, support, resistance, momentum, and the latest technical trading signals.
Disclaimer for Technical Analysis Page
The technical indicators and trading signals shown on this page are for informational purposes only and do not constitute financial advice. Stock market investments involve risk, and past performance is not a guarantee of future results. Always conduct your own research or consult a licensed financial advisor before making investment decisions.Read our Full DisclaimerCTKB Technical Analysis Summary (NASDAQ)
Cytek Biosciences, Inc. (NASDAQ: CTKB) stock currently shows a neutral trend on the NASDAQ, supported by momentum and balanced buying pressure.
Technical conditions suggest Cytek Biosciences, Inc. on the NASDAQ is awaiting a decisive move. This mix signals that Cytek Biosciences, Inc. is trading in a balanced range with no clear breakout yet.
RSI (14): 53.26
Stochastic %K: 63.16
Williams %R: -38.10
Rate of Change (ROC): -1.27
Takeaway:Cytek Biosciences, Inc. shows steady upward momentum, supported by improving signals.
MACD: 0.05
ADX: 16.24
ATR (14): 0.22
CCI (14): 29.67
Takeaway:Cytek Biosciences, Inc. shows a neutral trend, with weak conviction and limited volatility.
Takeaway:Cytek Biosciences, Inc. trades around the middle band, reflecting balanced price action.
Takeaway:Cytek Biosciences, Inc. trades above the trend line, showing healthy momentum within the channel.
Overall Takeaway:CTKB shows mixed signals in money flow analysis.
Bullish Signals
RSI above 50 → positive momentum from buyers.
MACD above 0 → bullish trend confirmation.
Price trading above middle Bollinger Band → mid-term support intact.
MFI below 80 → room for more buying without overbought risk.
Bearish Signals
No significant bearish signals detected.
Overall Recommendation:Cytek Biosciences, Inc. shows a Neutral outlook — indicators suggest balanced momentum with no clear directional trend.